Preemptive therapy in the prevention of cytomegalovirus disease in high- and low-risk heart transplant recipients

Transplantation Proceedings

Volumn 44, Issue 7, 2012, Pages 2113-2114

  Casquero, S ^a   Rangel, D ^a   Lage, E ^a   Sobrino, M ^a   Cristobo, P ^a   Cordero, E ^a   Cisneros, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR;

ADVERSE OUTCOME; ANTIGEN BLOOD LEVEL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG COST; ECONOMIC ASPECT; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEROLOGY; UNIVERSITY HOSPITAL; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE;

COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; HEART TRANSPLANTATION; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84866335435     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.07.066     Document Type: Conference Paper

References (7)

1. J.A. Fishman, R.H. Rubin Infection in organ transplant recipients N Engl J Med 357 2007 2601
2. J. de la Torre-Cisneros GESITRA-SEIMC/REIPI reccommendations for the management of cytomegalovirus infection in solid-organ transplan patients Enferm Infecc Microbiol Clin 2011 doi.org/10.1016/j.eimc.2011.05.022
3. B. Marzouk-Hidalgo, J.M. Cisneros, E. Cordero Therapeutic effect of the acqusition of cytomegalovirus-specific immune response during preemptive treatment Transplantation 91 2011 927
4. A.J. Eid, R.R. Razonable New developments in the management of cytomegalovirus infection after solid organ transplantation Drugs 70 2010 965
5. L. Poeta Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients J Heart Lung Transplant 28 2009 461
6. H.Y. Sun, M.M. Wagener, N. Singh Prevention of postransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review Am J Transplant 8 2008 2111
7. J.M. Iwasenko, G.M. Scott, Z. Naing, A.R. Glanville, W.D. Rawlinson Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients Transpl Infect Dis 13 2011 145